SEASONS BIOTECH
GenericsSEASONS BIOTECH is a generic drug manufacturer focused on Cardiovascular, Respiratory.
SEASONS BIOTECH's Key Drugs
SEASONS BIOTECH's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
SEASONS BIOTECH's Recent FDA Approvals
New NDA/BLA approvals for SEASONS BIOTECH over the last two years — novel drugs only, excluding generics and label supplements.
SEASONS BIOTECH's Therapeutic Areas
SEASONS BIOTECH's approved drugs and pipeline span 2 therapeutic areas, led by Cardiovascular and Respiratory. Weighted by commercial stage — approved drugs count most, then late-stage trials.
SEASONS BIOTECH's Top Competitors
SEASONS BIOTECH's closest competitors by therapeutic-area and drug-target overlap include Novartis, Merck, and Bayer. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
SEASONS BIOTECH Pipeline Snapshot
Active clinical trials for SEASONS BIOTECH across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Cardiovascular pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2025-12-03
- Latest
- 2026-05-19
- Applications
- 1